DAFNA Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-75,000
| Closed | -$1.73M | – | 95 |
|
|
2020
Q4 | $1.73M | Hold |
75,000
| – | – | 0.51% | 42 |
|
|
2020
Q3 | $764K | Hold |
75,000
| – | – | 0.25% | 62 |
|
|
2020
Q2 | $1.12M | Hold |
75,000
| – | – | 0.32% | 53 |
|
|
2020
Q1 | $914K | Hold |
75,000
| – | – | 0.38% | 53 |
|
|
2019
Q4 | $1.19M | Hold |
75,000
| – | – | 0.41% | 55 |
|
|
2019
Q3 | $921K | Hold |
75,000
| – | – | 0.35% | 60 |
|
|
2019
Q2 | $990K | Buy |
+75,000
| New | +$990K | 0.37% | 59 |
|